{{Drugbox
| IUPAC_name               = 10-(cyclopropylmethyl)-1-ethyl-13,13-dimethyl-10-azatricyclo[7.3.1.0<sup>2,7</sup>]trideca-2,4,6-trien-4-ol
| image                    = Gemazocine structure.svg
| CAS_number               = 54063-47-7
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 219096
| ChemSpiderID             = 189916
| ChEMBL = 2105066
| C = 20 | H = 29 | N = 1 | O = 1
| molecular_weight         = 299.450 g/mol
| smiles                   = Oc1ccc4c(c1)C2(C(C(N(CC2)CC3CC3)C4)(C)C)CC
| StdInChI                 = 1S/C20H29NO/c1-4-20-9-10-21(13-14-5-6-14)18(19(20,2)3)11-15-7-8-16(22)12-17(15)20/h7-8,12,14,18,22H,4-6,9-11,13H2,1-3H3
| StdInChIKey              = AFZOCGNTFCGOEE-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Gemazocine''' ('''R-15,497'''), also known as '''cyclogemine''', is a non-selective [[opioid antagonist]] of the [[benzomorphan]] class.<ref name="Macdonald1997">{{ cite book | author = Macdonald, F. | title = Dictionary of Pharmacological Agents | url = https://books.google.com/books?id=DeX7jgInYFMC&pg=PA955 | accessdate = 22 April 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 955 }}</ref><ref name="Gelders1979">{{ cite journal | title = Structural Studies of Substituted 6,7-Benzomorphan Compounds. I. The Absolute Configuration of (−)-2-Cyclopropylmethyl-2'-hydroxy-5-ethyl-9,9-dimethyl-6,7-benzomorphan (Gemazocine) Hydrobromide | authors = Gelders, Y. G.; de Ranter, C. J.; Schenk, H. | journal = Acta Crystallographica B | year = 1979 | volume = 35 | issue = 3 | pages = 699–703 | doi = 10.1107/S0567740879004477 | url = http://scripts.iucr.org/cgi-bin/paper?S0567740879004477 }}</ref><ref name="pmid2850928">{{cite journal |vauthors=Verlinde C, De Ranter C | title = Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens | journal = Eur. J. Pharmacol. | volume = 153 | issue = 1 | pages = 83–7 |date=August 1988  | pmid = 2850928 | doi = 10.1016/0014-2999(88)90590-0| url = }}</ref> It may have [[partial agonist]] properties at some of the [[opioid receptor]]s, such as at the kappa receptor (as it induces dysphoric effects in humans), but seems to be generally antagonistic in its actions.<ref name="pmid6301311">{{ cite journal |author1=Freye, E. |author2=Hartung, E. |author3=Schenk, G. K. | title = Bremazocine: An Opiate That Induces Sedation and Analgesia without Respiratory Depression | journal = Anesthesia and Analgesia | year = 1983 | volume = 62 | issue = 5 | pages = 483–488 | pmid = 6301311 | doi = 10.1213/00000539-198305000-00005| url = http://www.anesthesia-analgesia.org/content/62/5/483.full.pdf | format = pdf }}</ref>

==References==
{{Reflist|2}}

{{Opioidergics}}

[[Category:Benzomorphans]]
[[Category:Opioid antagonists]]


{{nervous-system-drug-stub}}